FORM vs LFUS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FormFactor exhibits exceptional operational health with a Piotroski F-Score of 8/9 and a negligible debt-to-equity ratio of 0.03. However, the stock is currently experiencing a severe valuation disconnect, trading at $121.07—nearly 6x its growth-based intrinsic value ($20.06) and significantly above the analyst target price of $86.89. While earnings growth is explosive (131.8% YoY), the P/E ratio of 178.04 is unsustainable. The combination of aggressive insider selling and a bearish technical trend suggests the current price is driven by momentum rather than fundamental value.
LFUS presents a stable deterministic health profile with a Piotroski F-Score of 5/9 and exceptionally strong liquidity (Current Ratio 2.69). However, the stock is currently trading at its 52-week high following a massive 153% one-year rally, resulting in a stretched valuation with a PEG ratio of 2.46. While the company maintains a stellar 25-quarter earnings beat track record and healthy revenue growth, the current negative net profit margin and ROE are concerning. With a technical trend score of 10/100 and bearish insider activity, the stock appears to be in a consolidation or peak phase.
Compare Another Pair
Related Comparisons
FORM vs LFUS: Head-to-Head Comparison
This page compares FormFactor, Inc. (FORM) and Littelfuse, Inc. (LFUS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.